Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19

The onset of the 2019 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated the identification of approved drugs to treat the disease, before the development, approval and widespread administration of suitable vaccines. To identify such a drug, we used a visual analytics...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Daniel P., Oechsle, Olly, Rawling, Michael J., Savory, Ed, Lacoste, Alix M.B., Richardson, Peter John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356560/
https://www.ncbi.nlm.nih.gov/pubmed/34393789
http://dx.doi.org/10.3389/fphar.2021.709856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356560/
https://www.ncbi.nlm.nih.gov/pubmed/34393789
http://dx.doi.org/10.3389/fphar.2021.709856

Ejemplares similares